Literature DB >> 8997544

Comparing non-hierarchical models: application to non-linear mixed effects modeling.

E I Ette1.   

Abstract

There is no method available to compare the fit of two non-hierarchical non-linear mixed effects models, although the common practice is to select the model with the lower objective function. Bootstrapping the log-likelihood differences (LLDs) of non-hierarchical models and constructing a bootstrap confidence interval on the LLDs is proposed for comparing the goodness-of-fit of such models. This is illustrated with different parameterizations of clearance models for an anti-infective agent in a longitudinal pharmacokinetic study which are compared. Additive and exponential models of creatinine clearance as a predictor of clearance are used as examples.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997544     DOI: 10.1016/s0010-4825(96)00031-5

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  6 in total

1.  Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.

Authors:  Ene I Ette; Leonard C Onyiah
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jul-Sep       Impact factor: 2.441

2.  Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study.

Authors:  Yogesh T Patel; Megan O Jacus; Nidal Boulos; Jason D Dapper; Abigail D Davis; Pradeep K Vuppala; Burgess B Freeman; Kumarasamypet M Mohankumar; Stacy L Throm; Richard J Gilbertson; Clinton F Stewart
Journal:  Cancer Chemother Pharmacol       Date:  2015-02-28       Impact factor: 3.333

3.  Covariate detection in population pharmacokinetics using partially linear mixed effects models.

Authors:  Peter L Bonate
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

4.  Methodological comparison of in vitro binding parameter estimation: sequential vs. simultaneous non-linear regression.

Authors:  C Steven Ernest; Andrew C Hooker; Mats O Karlsson
Journal:  Pharm Res       Date:  2010-03-11       Impact factor: 4.200

5.  Population pharmacokinetics and bioavailability of motexafin gadolinium (Xcytrin) in CD1 mice following intravenous and intraperitoneal injection.

Authors:  G W Boswell; D R Miles; P A Thiemann; M Mesfin
Journal:  Invest New Drugs       Date:  2006-07       Impact factor: 3.850

6.  Evaluation of uncertainty parameters estimated by different population PK software and methods.

Authors:  Céline Dartois; Annabelle Lemenuel-Diot; Christian Laveille; Brigitte Tranchand; Michel Tod; Pascal Girard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-01-10       Impact factor: 2.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.